Paul J Nietert Selected Research

Length of Stay

1/2019	Analysis of racial differences in hospital stays in the presence of geographic confounding.
1/2016	Triage sepsis alert and sepsis protocol lower times to fluids and antibiotics in the ED.
6/2012	Meta-analysis of bleeding complications associated with cardiac rhythm device implantation.
9/2009	Influence of age on racial disparities in stroke admission rates, hospital charges, and outcomes in South Carolina.
10/2005	Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Nietert Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 01/2008
5	Neoplasms (Cancer) 09/2023 - 03/2004
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2017 - 04/2003
4	Stroke (Strokes) 01/2019 - 10/2004
4	Hypertension (High Blood Pressure) 11/2014 - 04/2004
3	Chronic Pancreatitis 01/2024 - 01/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2021 - 01/2020
3	Atherosclerosis 01/2021 - 01/2019
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 05/2011
3	Heart Failure 01/2018 - 10/2005
3	Breast Neoplasms (Breast Cancer) 01/2017 - 12/2009
3	Heart Arrest (Cardiac Arrest) 01/2014 - 01/2014
3	Respiratory Tract Infections (Respiratory Tract Infection) 06/2013 - 08/2012
3	Systemic Scleroderma (Systemic Sclerosis) 05/2011 - 07/2007
3	Infections 06/2008 - 07/2007
2	Disease Progression 01/2023 - 11/2021
2	Body Weight (Weight, Body) 01/2022 - 05/2002
2	Pre-Eclampsia (Preeclampsia) 10/2020 - 11/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2018 - 05/2011
2	Sepsis (Septicemia) 01/2016 - 01/2002
2	Inflammation (Inflammations) 04/2015 - 02/2014
2	Hepatorenal Syndrome 01/2015 - 12/2011
2	Hypercholesterolemia 04/2003 - 07/2002
1	Deglutition Disorders (Dysphagia) 01/2024
1	Benign Fibrous Histiocytoma (Dermatofibroma) 12/2023
1	Dermatofibrosarcoma 12/2023
1	Hyperbilirubinemia 10/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Alcoholism (Alcohol Abuse) 01/2023
1	Pancreatitis 01/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2023
1	COVID-19 10/2022
1	Gliosis 01/2022
1	Tobacco Use Disorder (Nicotine Dependence) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2022
1	Cystic Fibrosis (Mucoviscidosis) 11/2021
1	Proteinuria 08/2021
1	Hematuria 08/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 08/2021
1	Lupus Nephritis 08/2021
1	Nephritis 08/2021

Drug/Important Bio-Agent (IBA)

5	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 12/2009
5	Immunoglobulin G (IgG)IBA 01/2017 - 06/2008
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 01/2008
4	CollagenIBA 12/2023 - 10/2007
4	CholesterolIBA 10/2017 - 07/2002
4	Genetic Markers (Genetic Marker)IBA 01/2017 - 06/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2015
3	Immunoglobulin Km AllotypesIBA 11/2021 - 06/2008
3	CreatinineIBA 08/2021 - 01/2014
3	CeramidesIBA 01/2021 - 01/2019
3	SphingolipidsIBA 01/2021 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 08/2011 - 06/2008
3	Immunoglobulin Gm AllotypesIBA 11/2010 - 07/2007
3	LipidsIBA 01/2008 - 04/2003
2	Amyloid (Amyloid Fibrils)IBA 12/2022 - 01/2022
2	SmokeIBA 01/2022 - 05/2002
2	AntigensIBA 11/2021 - 06/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2021 - 12/2014
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2021 - 02/2014
2	SphingosineIBA 01/2021 - 01/2019
2	SphingomyelinsIBA 01/2021 - 01/2019
2	Amyloid beta-PeptidesIBA 01/2020 - 01/2019
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019 - 01/2019
2	Vasoconstrictor AgentsIBA 01/2015 - 12/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014 - 12/2006
2	Connective Tissue Growth FactorIBA 05/2011 - 10/2007
2	AntibodiesIBA 11/2010 - 12/2009
2	Mucin-1 (CA 15-3 Antigen)IBA 12/2009 - 06/2008
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2007 - 07/2007
2	Antihypertensive Agents (Antihypertensives)IBA 04/2004 - 04/2003
1	BariumIBA 01/2024
1	BilirubinIBA 10/2023
1	Hematoxylin (Haematoxylon)IBA 09/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2023
1	Amylases FDA Link 01/2023
1	Polysaccharides (Glycans)IBA 01/2023
1	Mannose (D-Mannose)IBA 01/2023
1	NeuropeptidesIBA 01/2023
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2023
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 10/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 11/2021
1	Rituximab (Mabthera)FDA Link 08/2021
1	SteroidsIBA 08/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 04/2021
1	dihydrosphingosine 1-phosphateIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2024 - 12/2006
5	Length of Stay 01/2019 - 10/2005
3	Pancreatectomy 01/2024 - 01/2018
3	Autologous Transplantation 01/2024 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2023 - 02/2014
2	Advanced Cardiac Life Support (Life Support, Advanced Cardiac) 01/2014 - 01/2014
2	Secondary Prevention 12/2004 - 10/2004
1	Tonsillectomy 01/2022
1	Intravenous Infusions 01/2022
1	Adenoidectomy 01/2022
1	Transcranial Magnetic Stimulation 01/2022